Small Macular Holes Treated With Air
Small Macular Holes Treated With Air: A Prospective Randomized Controlled Multicenter Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Thessaly, Greece, 38221
- Not yet recruiting
- Department of Ophthalmology, University of Thessaly
-
Contact:
- Nikolaos Dervenis, Research associate
- Phone Number: +306936615677
- Email: nikosdervenis@gmail.com
-
Contact:
- Sofia Androudi, Associate Professor
- Phone Number: +306932654030
- Email: androudi@otenet.gr
-
Principal Investigator:
- Nikolaos Dervenis, Research associate
-
Sub-Investigator:
- Sofia Androudi, Associate Professor
-
-
-
-
-
Oslo, Norway, 0424
- Recruiting
- Oslo University Hospital
-
Contact:
- Marta Haugstad, MD
- Phone Number: +4795773548
- Email: UXARGS@ous-hf.no
-
Contact:
- Ingar Stene-Johansen, MD
- Phone Number: +4794037570
- Email: UXINTE@ous-hf.no
-
Principal Investigator:
- Marta Haugstad, MD
-
Sub-Investigator:
- Ingar Stene-Johansen, MD
-
-
Rogaland
-
Stavanger, Rogaland, Norway, 4026
- Recruiting
- Stavanger University Hospital
-
Contact:
- Vegard A Forsaa, PhD
- Phone Number: +4748152212
- Email: forsaa@gmail.com
-
Contact:
- Birger Lindtjorn, PhD
- Phone Number: +4795826869
- Email: birgerl@gmail.com
-
Principal Investigator:
- Vegard A Forsaa, PhD
-
Sub-Investigator:
- Birger Lindtjorn
-
-
Troms
-
Tromsø, Troms, Norway, 9019
- Recruiting
- University Hospital of Northern Norway
-
Contact:
- Kristian A Fossen, MD
- Phone Number: +4747029181
- Email: kristian.fossen@unn.no
-
Contact:
- Nina K Angelsen, MD
- Email: Nina.Kroll.Angelsen@unn.no
-
Principal Investigator:
- Kristian A Fossen, MD
-
Sub-Investigator:
- Nina K Angelsen, MD
-
-
Tronderlag
-
Trondheim, Tronderlag, Norway, 7030
- Recruiting
- St. Olavs University Hospital
-
Contact:
- Dordi K Austeng, PhD
- Phone Number: +4747352135
- Email: dordi.austeng@ntnu.no
-
Contact:
- Terje G Fagerholt, MD
- Phone Number: +4793223924
- Email: Terje.Giske.Fagerholt@stolav.no
-
Principal Investigator:
- Dordi K Austeng, PhD
-
Sub-Investigator:
- Terje G Fagerholt, MD
-
-
Vestland
-
Bergen, Vestland, Norway, 5021
- Recruiting
- Haukeland University Hospital
-
Contact:
- Joergen G Krohn, PhD
- Phone Number: +4790622668
- Email: joerkroh@online.no
-
Contact:
- Pal Varhaug, MD
- Phone Number: +4790642717
- Email: palvarhaug@helse-bergen.no
-
Principal Investigator:
- Joergen G Krohn, PhD
-
Sub-Investigator:
- Pal Varhaug, MD
-
-
-
-
La Coruna
-
Santiago De Compostela, La Coruna, Spain, 15706
- Recruiting
- Clinical Universitary Hospital of Santiago
-
Contact:
- Joaquin Marticorena, PhD
- Phone Number: +34981951757
- Email: jmarticorena@gmail.com
-
Principal Investigator:
- Maria Jose Teijeiro
-
Sub-Investigator:
- Joaquin Marticorena
-
Contact:
- Maria Jose Teijeiro
- Phone Number: +34981951757
- Email: mjblantei@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary MH ≤250 μm
- MH duration ≤12 months
- No previous vitreoretinal surgery in study eye
- Ability to sign informed consent
- Signed informed consent
- Age ˃18 years
Exclusion Criteria:
- Previous vitreoretinal surgery in study eye
- Secondary MH caused by other conditions than vitreomacular traction
- Myopic MH, i.e., excessive myopia (more than -6 dioptres)
- Traumatic MH
- MH secondary to retinal detachment or other retinal diseases
- Previously participation in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Gas tamponade
Intravitreal gas tamponade
|
Flushing the eye cavity with a tamponade at the end of surgery
|
|
Experimental: Air tamponade
Intravitreal Air tamponade
|
Flushing the eye cavity with a tamponade at the end of surgery
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Macular hole closure after single surgery
Time Frame: 4 weeks
|
Closure verified on OCT
|
4 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in outcome of patient well-being
Time Frame: 4 weeks and 4 months
|
Questionnaire
|
4 weeks and 4 months
|
|
Change in visual acuity i ETDRS lines
Time Frame: 4 weeks and 4 months
|
Early Treatment of Diabetic Retinopathy Score in logMAR.
Higher scores mean a worse outcome
|
4 weeks and 4 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REK 580226
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.